4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-15-000467
CIK 0001597553operating
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 1:44 PM ET
Size
10.7 KB
Accession
0001562180-15-000467
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Sale
Common Stock
2015-06-08$79.95/sh−4,300$343,785→ 7,200 total - Sale
Common Stock
2015-06-08$78.56/sh−1,200$94,272→ 6,000 total - Exercise/Conversion
Stock Options (Right to buy)
2015-06-08−5,500→ 132,169 totalExercise: $8.92Exp: 2024-05-21→ Common Stock (5,500 underlying) - Exercise/Conversion
Common Stock
2015-06-08$8.92/sh+5,500$49,060→ 11,500 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This transaction was executed in multiple trades at prices ranging from $79.15 USD to $80.09 USD. The price reported above reflects the weighted average sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $78.26 USD to $78.96 USD. The price reported above reflects the weighted average sale price.
- [F4]The option, representing a right to purchase a total of 137,669 shares, became partially exercisable beginning on May 05, 2015. 25% of this option vested on May 05, 2015 and the remainder vests in equal monthly installments thereafter over 36 months.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Jun 7, 8:00 PM ET
- Accepted
- Jun 8, 1:44 PM ET
- Size
- 10.7 KB